Zadimac PS 250mg/31.5mg Injection
Marketer
Macleods Pharmaceuticals Pvt Ltd
Salt Composition
Ceftazidime (250mg) + Tazobactum (31.5mg)
Overview Zadimac PS 250mg/31.5mg Injection
Combiflox, a 250mg/31.5mg injectable dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be solely under medical guidance; strict adherence to the prescribed dosage schedule is crucial for complete treatment efficacy, even with symptom improvement. Premature cessation may compromise therapeutic effectiveness. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical attention. Seek emergency care for allergic reactions (rash, itching, edema, dyspnea). Inform your physician of all current medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving, avoid operation of vehicles if experiencing somnolence or vertigo. Adequate rest, balanced nutrition, and hydration promote faster recovery. Monitoring may include laboratory tests to assess the drug's impact.
Uses of Zadimac PS 250mg/31.5mg Injection
Infections caused by bacteria
Major Benefits of Zadimac PS 250mg/31.5mg Injection:
The medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Zadimac PS 250mg/31.5mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Zadimac PS 250mg/31.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Zadimac PS 250mg/31.5mg Injection works:
Ceftazidime/Tazobactam (Zadimac PS 250mg/31.5mg Injection) unites two active agents to combat bacterial infections. The antibiotic Ceftazidime disrupts bacterial cell wall synthesis, hindering their ability to survive. Tazobactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby bolstering Ceftazidime's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Zadimac PS 250mg/31.5mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Zadimac PS, containing 250mg/31.5mg, is typically regarded as safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nonetheless, clinical data from human subjects are currently insufficient.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can safely use Zadimac PS 250mg/31.5mg Injection. Research in humans indicates negligible transfer of the medication into breast milk, posing no known risk to the infant.
DrivingUNSAFE
Administration of Zadimac PS 250mg/31.5mg Injection can induce drowsiness, visual disturbances, and dizziness. Driving should be avoided if these effects manifest.
KidneyCAUTION
Exercise caution when administering Zadimac PS 250mg/31.5mg Injection to individuals with impaired kidney function; dosage modification may be necessary. Physician consultation is recommended.
LiverCAUTION
For patients with severe hepatic impairment, administration of Zadimac PS 250mg/31.5mg Injection requires careful monitoring. Dosage modification of Zadimac PS 250mg/31.5mg Injection may be necessary. Physician consultation is recommended.
What if you forget to take Zadimac PS 250mg/31.5mg Injection :
Omitting a scheduled dose of Zadimac PS 250mg/31.5mg Injection necessitates contacting your physician.
Facts to Know About Zadimac PS 250mg/31.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently